Great Point Partners Makes $10 Million Growth Recapitalization Investment in iVantage Health Analytics
GREENWICH, CT and PORTLAND, June 7, 2013 (GLOBE NEWSWIRE) -- via PRWEB - Great Point Partners, LLC, a Greenwich-based private investment firm focused on the health care industry, today announced a $10M growth recapitalization investment in iVantage Health Analytics ("iVantage") from its second private equity fund GPP II. iVantage was formed in August 2011 through the merger of four existing and established health care informatics companies and is a leading provider of health care business analytics solutions to hospitals. The Company is led by a highly credentialed management team including:
- Hud Connery, Jr., former COO of HealthTrust and CEO/Founder of Essent Healthcare;
- Thomas Day, former Vice President and Corporate Officer of health care at Bain & Company and former CFO of the Advisory Board Company;
- John Morrow, former SVP at Healthgrades and HCIA/Solucient/Thomson Reuters Healthcare; and
- Thomas S. Hutchinson, former SVP at HealthStream Research.
iVantage's solutions help transform complex clinical and financial data into actionable business intelligence, and this platform is used by hospital management teams to drive empirical and evidence based decision making. The differentiated solution is able to displace incumbent siloed data solutions by providing hospitals with an integrated product suite across clinical, functional, and population/market analytics. These tools are positioned at the center of a large market opportunity due to increased demand for meaningful data driven by new compliance based requirements and operational challenges of the Patient Protection and Affordable Care Act ("PPACA").
The equity investment will fund expanded sales and marketing efforts, additional investment in technology infrastructure and personnel expansion.
"Great Point demonstrated intimate knowledge of the analytics sector since our initial meeting", said Hud Connery, CEO of iVantage. "Their deep network, industry insight, and capital investment will allow us to accelerate our next phase of growth. We are pleased to have an investor of the caliber and reputation of Great Point Partners join us as a shareholder."
"We've been in constant dialogue with hospital executives since the passing of health care reform", said Brett Carlson, Senior Vice President at Great Point Partners. "The widespread consensus is that clinical, functional, and market analytics are necessary and will provide users significant competitive advantages in navigating the complexities of the new environment."
Jeffrey Jay M.D. Managing Director added, "iVantage will utilize the funding to execute its long-term growth strategy and deliver innovative solutions as the Company expands into new markets and develops and/or executes new products."
About iVantage Health Analytics
iVantage is a leading provider of health care informatics and business analytics solutions that transform complex data into actionable business intelligence. This platform is used by hospital management teams to drive empirical and evidence based decision making. These tools are positioned at the center of a large market opportunity due to increased demand for meaningful data driven by new compliance based requirements and operational challenges of the Patient Protection and Affordable Care Act ("PPACA"). iVantage has been growing at approximately 50% per year. Visit http://www.ivantagehealth.com for additional information or call John Morrow at 207-218-2058.
About Great Point Partners
Great Point Partners ("GPP"), founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with approximately $600 million of equity capital under management. GPP is currently investing from GPP II, which is targeted at $200 million. Great Point manages capital in private and public equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 health care companies. Both the private and public funds invest across all sectors of the health care industry including biologics and pharmaceutical infrastructure, diagnostics, health care services, hospital outsourcing, information technology, medical devices, specialty pharmaceuticals, and workers compensation. The firm pursues a proactive and proprietary approach to sourcing investments. Reach Great Point at 203-971-3300 http://www.gppfunds.com.
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2013/6/prweb10808300.htm
CONTACT: Great Point Partners Janel Griffin email@example.com (203) 971-3300